Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

PaperCitations, authors & open-access status

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 818 citations, 2004 year and green oa status.

818
Citations
2004
Year
green
OA Status

Related on ScholarIQ

Liping Wang
Author
Peptidase Inhibition and Analysis
Topic
Peptidase Inhibition and Analysis
Topic
Diabetes Treatment and Management
Topic
Adenosine and Purinergic Signaling
Topic
470M+ articles · free account